The Federal Trade Commission must act to combat anticompetitive drug pricing practices by pharmacy benefit managers in the US, senators were told today. Congress also must pass laws that restore the agency’s powers to collect monetary redress for consumers, experts testified at a commerce committee panel hearing.The Subcommittee on Consumer Protection, Product